Dillard's (DDS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Mar, 2026Executive summary
A merger agreement was executed for W.D. Company, Inc. to merge into the reporting company, with the latter surviving the merger; the transaction is structured to avoid dilution for current shareholders and maintain proportional ownership post-merger.
The merger consideration includes both stock and cash, distributed pro rata to WDC shareholders, with shares held by WDC becoming treasury stock and then cancelled.
The merger is subject to customary closing conditions, including shareholder and regulatory approvals, and may be terminated under specified circumstances, such as failure to obtain approvals or changes in tax law.
The merger is intended to qualify as a tax-free reorganization under Section 368(a)(1)(A) of the Internal Revenue Code.
Forward-looking statements highlight risks such as litigation, regulatory hurdles, and potential adverse business impacts from the merger process.
Voting matters and shareholder proposals
Shareholder approval is required by a majority of outstanding common stock, voting as a single class, and by a majority of shares present or represented by proxy at the meeting, per NYSE rules.
The board recommends shareholders vote in favor of the merger at the 2026 Annual Meeting.
A proxy statement will be filed and mailed to shareholders, containing detailed information about the merger and related interests.
Board of directors and corporate governance
The merger was reviewed and recommended by a special committee of independent directors and unanimously approved by the board.
Post-merger, the officers and directors of the surviving corporation will remain unchanged.
Certain directors and officers have interests in the merger, including roles as WDC shareholders and indemnification rights.
Latest events from Dillard's
- Stable annual results with strong cash position and record dividend, despite Q4 sales dip.DDS
Q4 202624 Feb 2026 - Retail sales and net income rose 3% in Q3, with strong cash flow and a $30 special dividend.DDS
Q3 20255 Dec 2025 - Director nominee Warren A. Stephens resigned; board seat to remain vacant until replacement elected.DDS
Proxy Filing2 Dec 2025 - Shareholders are voting on reincorporation to Texas, aiming for legal, tax, and governance benefits.DDS
Proxy Filing2 Dec 2025 - 2025 proxy covers director elections, auditor ratification, pay-for-performance, and governance.DDS
Proxy Filing2 Dec 2025 - Proposal seeks shareholder approval to reincorporate from Delaware to Texas, preserving rights and reducing risk.DDS
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the May 2025 annual meeting agenda.DDS
Proxy Filing2 Dec 2025 - Q2 2025 retail sales rose 1% with strong cash flow, stable EPS, and ongoing share repurchases.DDS
Q2 20255 Sep 2025 - Net income and sales fell, but gross margin stayed strong and a $25 dividend was declared.DDS
Q3 202413 Jun 2025